Insider Trading & Ownership - HASTINGS DAVID C

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for HASTINGS DAVID C
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-02
Sale
2024-02-05
7:54 pm
Arbutus Biopharma CorpABUSHASTINGS DAVID C
Chief Financial Officer
9,593$2.3125$22,184631,907
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-20
Option Award
2024-06-21
4:10 pm
N/A
2034-06-19
SCYNEXIS INCSCYXHASTINGS DAVID C
Director
23,000$069,183
(Direct)
View
2024-02-01
Option Award
2024-02-05
7:54 pm
N/A
2034-02-01
Arbutus Biopharma CorpABUSHASTINGS DAVID C
Chief Financial Officer
562,500$0631,907
(Direct)
View
2023-06-15
Option Award
2023-06-23
4:08 pm
N/A
N/A
SCYNEXIS INCSCYXHASTINGS DAVID C
Director
10,000$023,183
(Direct)
View
2023-06-15
Option Award
2023-06-20
8:06 pm
N/A
2033-06-14
SCYNEXIS INCSCYXHASTINGS DAVID C
Director
10,000$010,000
(Direct)
View
2023-02-01
Option Award
2023-02-03
4:11 pm
N/A
2033-02-01
Arbutus Biopharma CorpABUSHASTINGS DAVID C
Chief Financial Officer
395,000$0395,000
(Direct)
View

Ownership
2023-01-03
9:04 pm
N/A
2038-01-02
Vascular Biogenics Ltd.VBLTHASTINGS DAVID C
Director
0$0224,113
(Direct)
View
2022-07-11
Disposition
2022-07-11
4:05 pm
N/A
N/A
Entasis Therapeutics Holdings Inc.ETTXHASTINGS DAVID C
Director
27,500$2.20
(Direct)
View
2022-07-07
Equity Swap
2022-07-11
4:05 pm
N/A
N/A
Entasis Therapeutics Holdings Inc.ETTXHASTINGS DAVID C
Director
22,000$2.20
(Direct)
View
2022-07-11
Other
2022-07-11
4:05 pm
N/A
N/A
Entasis Therapeutics Holdings Inc.ETTXHASTINGS DAVID C
Director
37,583$00
(Direct)
View
2022-06-17
Option Award
2022-06-22
4:06 pm
N/A
2032-06-16
SCYNEXIS INCSCYXHASTINGS DAVID C
Director
10,000$023,183
(Direct)
View
2021-07-16
Disposition
2022-02-15
4:01 pm
N/A
2028-04-30
Entasis Therapeutics Holdings Inc.ETTXHASTINGS DAVID C
Director
34,560$026,583
(Direct)
View
2021-07-16
Option Award
2022-02-15
4:01 pm
N/A
2031-07-15
Entasis Therapeutics Holdings Inc.ETTXHASTINGS DAVID C
Director
26,583$026,583
(Direct)
View
2022-01-20
Option Award
2022-01-20
5:55 pm
N/A
2032-01-20
Arbutus Biopharma CorpABUSHASTINGS DAVID C
Chief Financial Officer
285,000$2.81285,000
(Direct)
View
2022-01-18
Option Award
2022-01-19
4:01 pm
N/A
N/A
Entasis Therapeutics Holdings Inc.ETTXHASTINGS DAVID C
Director
27,500$049,500
(Direct)
View
2021-06-16
Option Award
2021-06-21
08:31 am
N/A
2031-06-15
SCYNEXIS INCSCYXHASTINGS DAVID C
Director
10,000$010,000
(Direct)
View
2021-04-01
Option Award
2021-04-02
10:33 am
N/A
N/A
Entasis Therapeutics Holdings Inc.ETTXHASTINGS DAVID C
Director
22,000$022,000
(Direct)
View
2020-07-06
Option Award(A)
2021-03-31
4:04 pm
N/A
2030-07-05
SCYNEXIS INCSCYXHASTINGS DAVID C
Director
55,000$055,000
(Direct)
View
2021-02-13
Option Award
2021-02-17
5:06 pm
N/A
2031-02-13
Arbutus Biopharma CorpABUSHASTINGS DAVID C
Chief Financial Officer
250,000$0250,000
(Direct)
View
2020-06-10
Option Award
2020-10-06
4:32 pm
N/A
2030-06-09
Entasis Therapeutics Holdings Inc.ETTXHASTINGS DAVID C
Director
11,000$011,000
(Direct)
View
2020-07-06
Option Award
2020-07-08
4:11 pm
N/A
2030-07-05
SCYNEXIS INCSCYXHASTINGS DAVID C
Director
45,000$045,000
(Direct)
View
2020-02-17
Option Award
2020-02-19
08:03 am
N/A
2030-02-17
Arbutus Biopharma CorpABUSHASTINGS DAVID C
Chief Financial Officer
100,000$0100,000
(Direct)
View
(A) Indicate amendment filing.